MedWatch

CHMP recommends Moderna covid-19 vaccine for approval in 12-17-year-olds

From now on, children aged between 12-17 may receive the Moderna vaccine against covid-119, according to the EU CHMP. The Danish Health Authority is taking note.

Photo: JUAN MEDINA/REUTERS / X01625

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has approved the use of Moderna’s covid-19 vaccine Spikevax on children aged 12-17, according to an EMA press release

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs